Perspective: on the future of fecal microbiota transplantation
- PMID: 39314882
- PMCID: PMC11418603
- DOI: 10.3389/fmicb.2024.1449133
Perspective: on the future of fecal microbiota transplantation
Abstract
Fecal Microbiota Transplantation (FMT) has shown to possess impressive potential benefit for a wide range of clinical indications. Due to its inherent safety issues and efficacy constraints, the use of personalized FMT analogs could be a promising avenue. The development of such analogs will require a detailed understanding of their functionality, encompassing not only microbe-host interactions of the microbial taxa that are involved, but also of the ecological dimensions of the analogs and an overview of the gastrointestinal sites where these relevant microbial interactions take place. Moreover, characterization of taxa that have been lost due to diminished exposure to beneficial microbes, as a consequence of Western lifestyle, may lead to creation of future FMT analogs with the capacity to restore functionalities that we have lost.
Keywords: One Health; analogs; fecal microbiota transplantation; gut microbiota; personalized; probiotics.
Copyright © 2024 Larsen and Brummer.
Conflict of interest statement
OL is Senior Manager Science at Yakult Nederland B. V. RB is also a member of the Scientific Advisory Board of The Akkermansia Company.
Similar articles
-
The role of the gut microbiome in colonization resistance and recurrent Clostridioides difficile infection.Therap Adv Gastroenterol. 2022 Nov 18;15:17562848221134396. doi: 10.1177/17562848221134396. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36425405 Free PMC article. Review.
-
Fecal Microbiota Transplantation in Experimental Ulcerative Colitis Reveals Associated Gut Microbial and Host Metabolic Reprogramming.Appl Environ Microbiol. 2018 Jul 2;84(14):e00434-18. doi: 10.1128/AEM.00434-18. Print 2018 Jul 15. Appl Environ Microbiol. 2018. PMID: 29728388 Free PMC article.
-
Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease.mBio. 2021 Aug 31;12(4):e0097521. doi: 10.1128/mBio.00975-21. Epub 2021 Jul 20. mBio. 2021. PMID: 34281401 Free PMC article. Clinical Trial.
-
Benefits of fecal microbiota transplantation: A comprehensive review.J Infect Dev Ctries. 2020 Oct 31;14(10):1074-1080. doi: 10.3855/jidc.12780. J Infect Dev Ctries. 2020. PMID: 33175698 Review.
-
Fecal microbiota transplants: A review of emerging clinical data on applications, efficacy, and risks (2015-2020).Qatar Med J. 2021 Feb 22;2021(1):5. doi: 10.5339/qmj.2021.5. eCollection 2021. Qatar Med J. 2021. PMID: 34604008 Free PMC article.
Cited by
-
The Potential Impact of Antibiotic Exposure on the Microbiome and Human Health.Microorganisms. 2025 Mar 5;13(3):602. doi: 10.3390/microorganisms13030602. Microorganisms. 2025. PMID: 40142495 Free PMC article. Review.
References
-
- Bachmann R., van Hul M., Baldin P., Léonard D., Delzenne N. M., Belzer C., et al. . (2022). Akkermansia muciniphila reduces peritonitis and improves intestinal tissue wound healing after a colonic transmural defect by a MyD88-dependent mechanism. Cells 11:2666. doi: 10.3390/cells11172666, PMID: - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources